Clinical Trial Update: 68Ga-PSMA HBED-PET/CT in the Evaluation of the Biochemical Relapse in Patients With a History of Prostate Cancer Radically Treated [NA]

View source ↗

Summary

A completed clinical trial evaluates Gallium-68 PSMA HBED-PET/CT imaging for evaluating biochemical relapse in men with a history of prostate cancer treated wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• 68Ga-PSMA HBED-PET/CT (Gallium-68 labeled PSMA HBED radiotracer for PET imaging)

Snippet

Sponsor: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | Conditions: 68Ga-PSMA HBED-PET/CT, Prostate Cancer | NA | Status: COMPLETED